Waipa Tablet ACT (Anti-malaria) x12

Waipa Tablet ACT is an Artemisinin Combination Therapy containing Dihydroartemisinin (30mg) and Piperaquine Phosphate (225mg) per tablet. This antimalarial medication provides effective treatment and prevention of malaria in patients of all ages.

Uses

Waipa ACT Tablet treats and prevents malaria caused by Plasmodium species. It’s effective against both sensitive and resistant malaria strains, making it suitable for use in endemic areas. Waipa is prescribed for patients from infancy through adulthood requiring antimalarial therapy.

Benefits

• Provides effective treatment for acute malaria episodes
• Offers prevention against malaria infection
• Works against drug-resistant Plasmodium strains
• Rapidly reduces fever and malaria symptoms
• Suitable for all age groups from infants to adults
• Requires short 3-day treatment course
• Demonstrates high cure rates in clinical studies
• Reduces risk of severe malaria complications
• Cost-effective antimalarial solution

How It Works

Dihydroartemisinin rapidly eliminates blood-stage malaria parasites through oxidative damage, providing quick symptom relief. Piperaquine phosphate has extended activity, clearing remaining parasites and preventing recurrence. This combination ensures complete parasite elimination while reducing resistance development.

Dosage

Take Waipa ACT tablets with water, preferably with food to improve absorption and reduce stomach irritation.

Duration of Action

Waipa ACT begins working within hours of administration, with fever typically subsiding within 24-48 hours. Dihydroartemisinin provides rapid parasite clearance within 48 hours, while Piperaquine offers prolonged protection against reinfection for several weeks after treatment completion.

Side Effects

Most patients tolerate Waipa ACT well. Common side effects include mild headache, dizziness, nausea, and abdominal discomfort. Some patients may experience temporary fatigue or loss of appetite. These effects are generally mild and resolve as treatment progresses.

Warning

Complete the full 3-day course even if symptoms improve early. Waipa ACT may cause heart rhythm changes in susceptible individuals. Seek immediate medical attention for severe vomiting, irregular heartbeat, seizures, or signs of severe allergic reaction. Not recommended for patients with known hypersensitivity to artemisinin derivatives.

Pregnancy and Breastfeeding

Waipa ACT can be used during the second and third trimesters when malaria poses significant risk. Use in first trimester only when benefits clearly outweigh potential risks. Limited data exists for breastfeeding mothers, though treatment is generally considered safe when malaria threatens maternal health.

Interaction

• May interact with medications affecting heart rhythm
• Possible reduced effectiveness with certain seizure medications
• May alter blood levels of some HIV medications
• Could affect effectiveness of oral contraceptives
• Grapefruit products may increase drug concentrations

Precaution

Use cautiously in patients with heart conditions, liver or kidney problems, or history of seizures. Monitor closely in elderly patients and those with electrolyte imbalances. Ensure proper malaria diagnosis before treatment when possible. Avoid crushing tablets for young children unless absolutely necessary.

Important Information

Waipa ACT is prescription medication requiring medical supervision for optimal results. Continue mosquito protection measures during and after treatment. If vomiting occurs within one hour of taking dose, repeat the dose. Consult healthcare provider if symptoms persist beyond treatment course. Store in cool, dry place away from direct sunlight and keep out of children’s reach.